Related by context. All words. (Click for frequent words.) 76 http:/www.clinicaltrials.gov 75 number NCT# ClinicalTrials.gov 74 http:/www.clinicaltrials.gov/ 74 www.ClinicalTrials.gov 74 www.clinicaltrials.gov 73 clinicaltrials.gov 70 ID NCT# 69 www.celsion.com 69 www.cellceutix.com 69 NCT# 68 ThermoDox ® clinical 68 Clinicaltrials.gov 67 ClinicalTrials.gov 66 www.vicortech.com 66 www.vioquestpharm.com 65 www.telik.com 65 http:/www.vical.com 65 FOLOTYN ® 65 www.incyte.com 65 www.micromet inc.com 65 www.asco.org 65 confirmatory Phase IIIb 64 http:/www.ariad.com 64 www.cardiome.com 64 Full Prescribing Information 64 http:/www.atherogenics.com 64 www.cancer.gov 64 www.allos.com 64 www.acusphere.com 64 clinicaltrials 64 www.micromet.com 64 www.xoma.com 64 Phase #b/#a clinical 64 www.stemcellsinc.com 64 www.syntapharma.com 64 Cellceutix web 64 PEARL SC 64 BRIM3 63 http:/www.curagen.com 63 Phase IIIb study 63 visit http:/www.clinicaltrials.gov/ 63 www.adeonapharma.com 63 www.vical.com 63 www.adventrx.com 63 www.niddk.nih.gov 63 Pafuramidine 63 http:/www.optimerpharma.com 63 www.accentia.net 63 www.nymox.com email info@nymox.com 63 phase IIIb 63 Phase 2b Clinical Trial 63 trastuzumab DM1 T DM1 63 galiximab 63 PROMACTA CARES 63 call #.#.NEXAVAR #.#.#.# 62 www.questcor.com 62 Combination REOLYSIN R 62 MEK Inhibitor 62 Completes Patient Enrollment 62 www.alexionpharma.com 62 www.cellgenesys.com 62 www.hythiam.com 62 designated HVTN 62 Nexavar prescribing 62 www.bdal.com 62 www.osteologix.com 62 www.orexigen.com 62 Hepatocellular Carcinoma HCC 62 www.anthera.com 62 www.vivus.com 62 www.avigen.com 62 www.verichipcorp.com 62 www.chembio.com 62 Prospective Randomized 62 Telik logo TELINTRA 62 www.roche 62 www.pranabio.com 62 www.bioalliancepharma.com 62 Dupuytren Contracture 62 Cloretazine ® 61 Medullary Thyroid Cancer 61 please visit http:/www.sunesis.com 61 Phase III Clinical Trial 61 Initiates Phase II 61 www.ltx.com 61 www.cougarbiotechnology.com 61 Current Controlled Trials 61 www.ziopharm.com 61 Initiates Phase III 61 www.varian.com 61 please visit www.advaxis.com 61 www.cambrex.com 61 www.biosantepharma.com 61 Phase III Pivotal 61 www.ingenuity.com 61 Initiates Clinical Trial 61 www.aidshealth.org 61 www.aryx.com 61 website www.celsion.com 61 recurrent metastatic ovarian cancer 61 www.cerus.com 61 non nucleoside HCV 61 www.sanofi aventis.us 61 novel VDA molecule 61 www.genome.gov 61 Truvada tablets 61 treatment naive genotype 61 Phase Ib II 61 website http:/www.celsion.com 61 Initiate Clinical Trial 61 Completes Dosing 61 www.novartis.com 61 Phase IIIb 61 Phase IIb III 61 Phase IIIb clinical 61 www.heartware.com 61 Demonstrates Positive 61 Initiates Enrollment 61 www.cticseattle.com 61 Pre RELAX AHF 61 alvespimycin 61 PANVAC VF 61 Maven Semantic 61 CYT# potent vascular disrupting 61 Pivotal Phase III 61 Oral Fingolimod 61 www.paintrials.com 61 Reports Preclinical Data 61 www.regenerx.com 61 dbGaP 60 Tumor Response 60 MAGE A3 ASCI 60 CALGB # [002] 60 http:/www.adventrx.com 60 R lenalidomide 60 www.durect.com 60 www.aacr.org 60 INSPIRE Trial Phase III 60 visit www.LifeVantage.com 60 HCV SPRINT 60 www.achillion.com 60 VITAL Trial 60 Oral Insulin Capsule 60 LibiGel ® 60 Triapine R 60 phase IIb clinical 60 phase IIb study 60 http:/www.unigene.com 60 www.bio rad.com 60 nih.gov 60 TNFerade TM 60 Severe Sepsis 60 www.gsk.com 60 EmbraceAC 60 metastatic neuroendocrine tumors 60 http:/www.marinabio.com 60 www.med 60 Phase III multicenter 60 Boxed Warnings 60 http:/www.staar.com 60 http:/www.reprosrx.com 60 Initiates Phase 2b 60 pharmacogenomic translational research 60 www.delcath.com 60 www.oncolyticsbiotech.com 60 www.pharsight.com 60 tramiprosate Alzhemed TM 60 oral ridaforolimus 60 www.ariad.com 60 Achieves Primary Endpoint 60 SYMMETRY trial 60 http:/www.orexigen.com 60 www.criticaloutcome.com 60 PDX pralatrexate 60 Phase IIb Clinical Trial 60 Tesmilifene 60 Protein Expression 60 www.sciclone.com 60 www.acegroup.com 60 http:/www.vivus.com 60 www.candelalaser.com 60 Confirms Efficacy 60 Advanced Melanoma 60 Recurrent Glioblastoma 60 Biomarker Study 60 NDA Submission 60 www.labopharm.com 60 TASKi2 60 www.ilgenetics.com 59 www.rideSTA.com 59 www.givenimaging.com 59 regarding Aethlon Medical 59 ClinicalTrials.gov Identifier NCT# 59 www.makosurgical.com 59 www.edventures.com 59 IIa Clinical Trial 59 www.geovax.com 59 mertansine 59 www.oxigene.com 59 BR.# 59 www.caliperLS.com 59 www.gpc biotech.com 59 www.amarincorp.com 59 GATTEX ® 59 www.oculusis.com 59 http:/www.pharmacopeia.com 59 http:/www.gpc-biotech.com 59 BUPHENYL R 59 please visit www.anci 59 THAT ARE DIFFICULT TO 59 sorafenib tablets 59 LungAlert TM 59 Phase IIb Trial 59 Phase 2b Study 59 Hepatocellular Carcinoma 59 Pyridorin TM 59 ExCell study 59 www.rosettabio.com 59 cancer.gov 59 Brentuximab Vedotin SGN 59 www.lonza.com 59 www.sanofi aventis.com 59 www.prometric.com 59 http:/www.gene.com/ 59 www.resverlogix.com 59 programs visit http:/www.bionovo.com 59 Phase IIB clinical 59 CB2 selective receptor agonist 59 Sapacitabine 59 www.malbex.ca 59 Phase 1a clinical 59 OncoVex 59 Therapeutic Vaccine 59 Fondaparinux 59 http:/www.BMRN.com 59 Randomized Phase II 59 Vaccine Protects Against 59 Clinical Antipsychotic Trials 59 clevidipine 59 Unstable Angina 59 www.nexiaholdings.com 59 Intervention Effectiveness 59 Randomized Controlled Trials 59 TO AVOID PREGNANCY WHILE 59 budesonide foam 59 Phase III ThermoDox 59 APEX AMI trial 59 www.sembiosys.com 59 assessing T DM1 59 Matrix Phase 2b 59 relapsing remitting MS RRMS 59 MEND CABG 59 Hedgehog Pathway Inhibitor 59 refractory chronic lymphocytic 59 cro.com 59 www.sematech.org 59 visit www.#.com 59 http:/www.idenix.com 59 www.helicosbio.com 59 DEB# 59 Presents Preclinical Data 59 www.advaxis.com 59 forodesine 59 visit www.sanofi aventis.us 59 Antigen Express website 59 Phase Ib clinical 59 Oral Calcitonin 59 recurrent metastatic 59 pralatrexate injection folate analogue 59 www.landesk.com 59 www.cmdiagnostics.com 59 Emerging Therapies 58 www.marshalledwardsinc.com 58 placebo controlled Phase III 58 news subscribe.htm 58 Metastatic Melanoma 58 Commences Phase 58 confirmatory clinical 58 www.phtcorp.com 58 kidney urologic 58 hyaluronidase enzyme 58 www.agennix.com 58 Randomized Double blind 58 JAK2 Inhibitor 58 UPLYSO 58 midstage trials 58 ZOLINZA 58 DAPT Study 58 www.artesmedical.com 58 www.sigma 58 Completes Enrollment 58 See WARNINGS 58 Patient Enrollment 58 Begins Dosing 58 please visit www.medicinova.com 58 Shows Promise Against 58 CHAMPION PCI 58 Phase 2a clinical trials 58 www.pgxhealth.com 58 See CLINICAL PHARMACOLOGY 58 Immunotherapeutic 58 Initiates Clinical 58 Shows Efficacy 58 ENESTnd 58 Pivotal Trial 58 http:/www.hematology.org 58 Randomized Evaluation 58 Vaccine Adjuvant 58 Pivotal Clinical Trial 58 visit smith.com 58 ongoing Phase 1b 58 REVIVE Diabetes 58 CEQ# 58 Diabetic Foot Ulcer 58 www.boehringer ingelheim.com 58 http:/www.npsp.com 58 http:/www.celgene.com 58 www.diagnocure.com 58 visit www.marrow.org 58 Aplidin R 58 Mg Usa 58 www.aethlonmedical.com 58 Investigational Drug 58 HCV RESPOND 2 58 Refractory Angina 58 rALLy trial 58 Nuvelo Announces 58 www.isecuretrac.com 58 prospective multicentre 58 clevudine 58 www.arqule.com 58 IL# PE#QQR 58 cMET 58 Pivotal Phase II 58 www.kla tencor.com 58 Phase IIB 58 multicenter clinical 58 Clinical Study 58 PET FROM 58 Veronate R 58 phase IIb trial 58 II Clinical Trial 58 http:/www.cticseattle.com 58 candidate CRLX# 58 cell.com 58 registrational Phase 58 Cloretazine 58 Visit GITA 58 Preclinical Efficacy 58 www.cancerconsultants.com 58 optimal dosing 58 Temsirolimus 58 Investigational Treatment 58 http:/www.torreypinestherapeutics.com 58 Ovarian PLCO Cancer 58 endometriosis ovarian cysts 58 Initiate Phase 58 Files IND 58 Intervention Effectiveness CATIE 58 Pandemic Influenza Vaccines 58 fosbretabulin 58 fidaxomicin Phase 3 58 CCR5 mAb 58 BRIM2 58 EXPLORE Xa 58 phase IIa clinical 58 Visit Xenonics 58 Acute Decompensated Heart Failure 58 www.prescriptionsolutions.com 58 Aurexis 58 Randomized Double Blind 58 bevirimat Study 58 www.morrishospital.org 58 Presents Positive 58 Prospective Multicenter 58 www.compumed.net 58 ExTRACT TIMI 58 www.interscience.wiley.com 58 non nucleoside inhibitor 57 ENDEAVOR IV 57 visit www.silvercross.org 57 WEB OF SCIENCE 57 recurrent glioblastoma multiforme 57 phase III isavuconazole 57 PROSTVAC ® 57 fidaxomicin Phase 57 www.criticalpath.net 57 Allovectin 7 R 57 HDAC Inhibitor 57 Phase 1b clinical trials 57 Submits NDA 57 Anturol TM 57 LEUKINE 57 LUX Lung 57 CURRENT OASIS 7 57 interferon gamma 1b 57 GTC recombinant human 57 www.royalcaribbean.com www.celebrity.com www.pullmAhmed Hilles clan 57 Pooled Analysis 57 pressroom pressroom.yahoo.com 57 XIENCE V Stent System 57 Clinical Trial Results 57 PUBMED 57 www.gene.com 57 Glufosfamide 57 http:/www.baxa.com 57 LUMINATE 57 www.opexatherapeutics.com 57 multicenter randomized clinical 57 including eniluracil ADH 57 Phase IIb clinical trials 57 Proellex TM 57 NCT# ClinicalTrials.gov 57 Pandemic Influenza Vaccine 57 multicenter Phase III 57 blinded randomized placebo controlled 57 Systemic Delivery 57 Nicotine Vaccine 57 www.adapx.com 57 phase Ib clinical 57 Carotid Revascularization Endarterectomy vs. 57 http:/www.JazzPharmaceuticals.com 57 Combination Treatment 57 www.iconplc.com 57 Phase III Clinical Trials 57 neratinib 57 PrevOnco 57 POSIDUR TM 57 Successfully Completes Phase 57 website www.iteknik.com 57 YONDELIS 57 Multicenter Randomized 57 Receives Orphan Drug 57 Phase 2a Trial 57 SUTENT ® 57 Raptiva ® 57 unique alkylating agent 57 Advanced Renal Cell 57 European Sepsis Trial 57 www.udetection.com 57 Entereg TM 57 First Patient Enrolled 57 www.adt.com 57 pharma.com 57 Panzem NCD 57 multicenter clinical trials 57 AVI BioPharma Announces 57 www.coade.com 57 www.igate.com 57 www.connectyx.com 57 #D#C# 57 IND Application 57 Ganite ® 57 specified primary endpoint 57 www.active 57 lintuzumab SGN 57 Acute Ischemic Stroke 57 Ozarelix 57 MGd 57 CUSTOM III 57 Phase III HEAT 57 Screening Trial 57 Tectin TM 57 CAMMS# 57 Prolongs Survival 57 Edge STudy 57 Prescribing Information 57 www.baxa.com 57 BiTE Antibody 57 Hsp# Inhibitor 57 www.accela.com 57 Chronic Heart Failure 57 Xelox 57 Varian Semiconductor maintains 57 Tanespimycin 57 brivanib 57 ENDEAVOR III 57 intravesical infusion therapy 57 Phase III randomized controlled 57 www.appliedenergetics.com 57 HepaSphere 57 Hematide ™ 57 MelaFind R 57 Pubmed 57 dirucotide MBP# 57 Anti Tumor 57 Long Term Efficacy 57 Trofex 57 ALTROPANE 57 Clinical Trial Evaluating 57 Aflibercept 57 Cardiotoxicity 57 Delcath Phase III 57 randomized controlled multicenter 57 www.anci care.com 57 Enzyme Replacement Therapy 57 pivotal bioequivalence 57 Preclinical Data 57 Clinical Trial Data 57 multicenter Phase II 57 CR# vcMMAE 57 site www.ElysiumInternet.com 57 www.synchronica.com 57 www.endeca.com 57 Aryplase 57 molecular imaging radiopharmaceutical 57 www.transgene.fr 57 acyclovir Lauriad R 57 Patient Enrolment 57 ENGAGE AF TIMI 57 Randomized Study 57 RELOVAIR ™ 57 By JENNIFER LEARN 57 www.immuneregen.com 57 Exherin TM 57 ThermoDox R 57 www.dctindustrial.com 57 www.lca vision.com 57 Pharmacokinetics PK 57 http:/www.durect.com 57 vapreotide acetate 57 Vaccine Candidate 57 Testosterone MDTS ® 57 metastatic GIST 57 Randomized Phase 57 NABTT 57 www.pbmi.com 56 Adjuvant Treatment 56 ENTB 56 Prostate AdenoCarcinoma Treatment 56 Tyrosine Kinase Inhibitor 56 Plaque Psoriasis 56 www.consumerlab.com 56 http:/www.monogrambio.com 56 NSABP B 56 ir.net 56 Phase Ib IIa 56 Therapeutic Efficacy 56 iii GTx 56 uricase 56 crizotinib PF # 56 Medidur TM FA 56 Personalized Immunotherapy 56 includes TOLAMBA TM 56 randomized discontinuation trial 56 www.charlesandcolvard.com 56 www.crowflight.com 56 preclinical efficacy 56 www.utcfireandsecurity.com 56 Cloretazine R 56 Confirmatory 56 www.flutest.com 56 OvaRex ® MAb 56 www.ecri.org 56 http:/www.diabetes.org 56 ospemifene 56 GATTEX ™ 56 histone deacetylase inhibitor 56 site www.depomedinc.com 56 recurrent malignant glioma 56 Oracea TM 56 Pivotal Study 56 Clinical Evaluation 56 Vaxfectin TM 56 Crofelemer budesonide foam 56 Genasense ® 56 Therapeutic Antibody 56 Granted Orphan Drug 56 HuCAL GOLD R 56 multicenter multinational 56 Phase III Trial 56 www.ttmtech.com 56 RECORD1 56 www.multimediagames.com 56 Kit CD# positive 56 Degarelix 56 papillary renal cell carcinoma 56 sci.com 56 torezolid phosphate 56 Pulmonary Arterial Hypertension 56 Malignant Melanoma 56 Diabetic Nephropathy 56 www.keithley.com events semconfs 56 Methylnaltrexone 56 GAMMAGARD 56 Metabolic Disease 56 Diabetic Neuropathy 56 ganetespib 56 LEARN MORE ABOUT 56 Pharmacokinetic Study 56 Multiple Ascending Dose 56 GRAVITAS trial 56 www.avatech.com 56 Shows Promising 56 Ranolazine 56 Afatinib 56 biliary tract cancer 56 PI3K/Akt pathway inhibitor 56 TASKi3 56 Completes Patient Enrolment 56 Fast Track Status 56 Immunosuppressant 56 www.cdc.gov nchs 56 EDEMA3 56 Universal Flu Vaccine 56 Receives Orphan Drug Designation 56 pain palliation 56 sarcoma melanoma 56 lenalidomide Revlimid R 56 Contraindications 56 ALTROPANE R 56 www.infinitiusa.com 56 www.tranzyme.com 56 http:/www.exonhit.com 56 Prostate Lung Colorectal 56 OvaRex R 56 Naive Patients 56 Initiate Phase II 56 www.astronics.com 56 response.enbridgeus.com 56 Phase 1b trial 56 Ovarian Cancer Screening 56 phase IIa 56 rNAPc2 56 TLK# 56 OMP #M# 56 star.edu.sg 56 www.evolving.com 56 treat chronic sinusitis 56 FDA Accepts 56 ATryn ® GTC recombinant 56 Elagolix 56 Visit Adeptron 56 PFO migraine 56 APEX PD 56 PERSEUS 56 Nymox NX 56 investigational therapies 56 budesonide MMX Phase III 56 Selective Electrochemical Tumor Ablation 56 C1 Inhibitor 56 Fabry Disease 56 NP2 Enkephalin 56 Zenvia Phase III 56 HCV NS5B polymerase 56 ongoing Phase IIIb 56 Recurrent Breast Cancer 56 plasma kallikrein inhibitor 56 hypoxia activated prodrug 56 rALLy clinical trial 56 PRECISE trial 56 AVERROES 56 SinuNase TM 56 PROTECT AF 56 Azedra 56 Somatuline R Autogel R 56 IMPACT DCM 56 visit www.quidel.com www.colorectal 56 DEEP AF 56 AAG geldanamycin analog 56 www.HirschElectronics.com 56 http:/www.questdiagnostics.com 56 Pivotal Phase 56 Improves Survival 56 dasatinib Sprycel ® 56 Schizophrenia Treatment 56 info@endeca.com 56 www.option.com 56 Maximum Tolerated Dose MTD 56 Demonstrates Significant 56 PROSTVAC TM 56 Dose Ranging Study 56 Visit NeuStar 56 www.panorama.com 55 Meets Primary Endpoint 55 Seliciclib 55 Drug Candidate 55 Phase Ib study 55 Patients Treated With 55 Topline Results 55 Gets FDA Clearance 55 call Oveda Slade 55 PROVENGE ® 55 Romidepsin 55 www.kmbs.konicaminolta.us 55 candidates Dyloject TM 55 AVOREN 55 TRANSDUR ® 55 granted Ortec 55 Safinamide 55 www.identive group.com 55 randomized Phase IIb 55 lorcaserin Phase 55 Daclizumab 55 Pharmacogenomic 55 Phase 2b Trial 55 IIa clinical 55 Curaxin CBLC# 55 Clostridium difficile Infection 55 Stem Cell Treatment 55 aldehyde dehydrogenase ALDH2 deficiency 55 recurrent glioma 55 site www.basinwater.com 55 Urocortin 2 55 FavId 55 Calcium Acetate 55 Diagnostic Tests 55 Golimumab 55 Antisense Drug 55 Gastrointestinal Oncology 55 oxypurinol 55 www.prosepinc.com 55 Acute Myocardial Infarction 55 TYGACIL 55 ELADUR ™ 55 Phase Ia 55 Present Preclinical Data 55 2 inhibitor CYT# 55 Patient Registry 55 Bayer HealthCare Onyx Pharmaceuticals 55 MKC# MKC# PP 55 Visit www.qsii.com 55 ISRCTN# 55 http:/www.cyberonics.com 55 Advaxis Phase 55 JAK Inhibitor 55 Entereg R 55 Alinia 55 http:/www.hauppauge.com 55 www.protus.com 55 www.hematology.org 55 Percutaneous Tibial Nerve Stimulation 55 www.sanbolic.com 55 KRN# 55 Aurora kinase inhibitor 55 huC# DM4 55 adjuvant GIST 55 Lydian web 55 depsipeptide 55 http:/www.altera.com 55 evaluating mipomersen 55 Novel Oral 55 MYCAMINE 55 dose escalation clinical 55 http:/www.symbol.com/ 55 please visit www.toyota.co.jp 55 EGS# 55 FULL PRESCRIBING INFORMATION 55 http:/www.wuxiapptec.com 55 logging onto www.gtc 55 www.cipherpharma.com 55 Commence Phase 55 QuadraSphere 55 Liprotamase 55 Sibutramine Cardiovascular Outcomes 55 Factor VIIa 55 placebo controlled clinical 55 www.medicalpropertiestrust.com 55 www.stevens.edu 55 Tuberculosis Vaccine 55 Phase Ib clinical trials 55 Silodosin 55 phase Ib 55 EVIZON TM 55 Presents Preclinical 55 Therapy Evaluation 55 http:/www.ovt.com 55 Randomized Clinical Trial 55 Mesothelioma Treatment 55 http:/www.nice.com 55 investigational antiplatelet agent 55 Androxal TM 55 www.bcbsga.com 55 www.gd 55 trastuzumab DM1 55 lucinactant 55 www.bayerhealthcare.com 55 NO# [002] 55 IMC #B 55 Metabolic Disorder 55 LymphoStat B TM 55 http:/ideas.live.com 55 virus HCV protease inhibitor 55 Initiate Phase III 55 guestlogix.com 55 randomized multicenter trial 55 EMBASE 55 MADIT II 55 BLA submission 55 PLCO 55 AZILECT ® 55 www.nstein.com 55 TKB# 55 http:/www.unitedfamilyhospitals.com 55 hoFH 55 phase IIb III 55 XL# SAR# 55 Phase #/#a 55 Phase 1b Clinical Trial 55 clinical trials SGN 55 R rosiglitazone maleate 55 nasal calcitonin product 55 www.capella.edu 55 ONCONASE R 55 AERAS-#/Crucell Ad# 55 Outpatient Setting 55 Pralatrexate 55 Embolic Protection Device 55 REC Solar visit www.recsolar.com 55 PREOS R 55 www.postilion.com 55 www.thompsoncreekmetals.com 55 Hepatotoxicity 55 RNAi Therapeutic 55 Archexin 55 Phase Ib Clinical Trial 55 Prostate Cancer Patients 55 lexidronam injection 55 prospective randomized multicenter 55 TRANSDUR ™ 55 Anti CD# Antibody 55 www.fei.com 55 hypereosinophilic syndrome 55 CLARITY TIMI 55 molecular chaperone regulator 55 Gastric Cancer 55 XL# anticancer compounds 55 dosage regimens 55 Risk Stratification 55 Phase 2b clinical trials 55 Androxal ® 55 DSMB recommended 55 Controlled Trial 55 Benign Prostatic Hyperplasia 55 Solid Tumors 55 CURE AF 55 Placebo Controlled Trial 55 Presents Positive Preclinical 55 AVN# Phase 55 Submits Biologics License Application 55 www.hitwise.com 55 fund BioSante LibiGel 55 PRIMO CABG2 55 Hemodialysis Patients 55 www.cablelabs.com 55 EDEMA3 trial 55 CINTREDEKIN BESUDOTOX 55 PD2i CA 55 Accelerated Partial Breast Irradiation 55 toenail onychomycosis 55 ASCO GI 55 Hormone Refractory Prostate Cancer 55 EGFr expressing metastatic colorectal 55 site http:/www.consolenergy.com 55 Teva Provides Update 55 www.NHCcare.com 55 http:/www.candelalaser.com 55 Left Ventricular Dysfunction 55 www.shavlik.com 55 http:/www.aarcorp.com 55 http:/www.informationbuilders.com 55 topically applied SEPA 55 ADAGIO study 55 Preclinical Study 55 LibiGel Phase III 55 care.org 55 novel emulsion formulation 55 Relapsing Multiple Sclerosis 55 Val HeFT 55 EchoCRT 55 recombinant interferon 55 www.ovt.com 55 PNP inhibitor 55 Lovaxin C 55 DIRECT Trial 55 www.questionmark.com 55 R roscovitine 54 Augment Injectable 54 Files Investigational 54 www.americaspower.org 54 Prodarsan R 54 dependent kinase inhibitor 54 HORIZONS AMI 54 Bezielle 54 Lung Cancer Drug 54 Phase III Trials 54 Optical Coherence Tomography 54 CIMZIA TM certolizumab pegol 54 oral FTY# 54 GRNVAC1 54 IgG1 monoclonal antibody 54 FDA APPROVES 54 investigational oral inhibitor 54 adjunctively 54 www.fticonsulting.com 54 www.bjsrestaurants.com 54 Postdoctoral Position 54 ADVANCE ILLUMINATE 54 Mylan Receives Approval 54 EVEREST II 54 Cannabinor 54 www.cablenet.org 54 investigational pan BCR 54 AIMM trial 54 Treat Anemia 54 www.ses newskies.com 54 ® decitabine 54 CATIE AD 54 Oral Insulin 54 MBRX 54 AIM HIGH 54 Anecdotal yodel.yahoo.com 54 gefitinib Iressa 54 SPERA 54 IND Filing 54 Second Pivotal Phase 54 Telavancin 54 Renal Cell Carcinoma RCC 54 www.returnpath.net 54 YOUR LOCAL ANIMAL SHELTER 54 DASISION 54 www.digirad.com 54 IMA# 54 randomized controlled Phase 54 durable pain palliation 54 ZYBRESTAT TM 54 Myelodysplastic Syndromes 54 Virulizin R 54 http:/www.biocactus.com 54 diarrhea predominant irritable 54 APPRAISE 54 Investigational Compound 54 Nasdaq PPHM 54 HepeX B TM 54 product platforms AZX# 54 riociguat 54 Prodarsan ® 54 Begin Clinical Trials 54 Cardiac Allograft Rejection 54 PEGylated anti 54 Investigational Device Exemption 54 www.idc.com 54 www.radian.biz 54 OMNARIS HFA 54 Clinical Outcome 54 Demonstrates Sustained 54 Xanafide 54 MIST II 54 Prostate Cancer Treatment 54 TMC# C# 54 teduglutide 54 Catheter Associated 54 http:/www.pervasive.com 54 TM pralatrexate injection 54 www.clickcommerce.com 54 Data Extraction 54 Outcome Sciences 54 MedLine 54 Panzem R NCD 54 TELCYTA 54 Pemetrexed 54 abstracts summarizing 54 www.nature.com 54 Pemphigus Vulgaris 54 OAB overactive bladder 54 Cellegesic 54 cUTI 54 www.cominar.com 54 vernakalant hydrochloride 54 Diabetic Patients 54 contacting COADE 54 DNA Methylation 54 www.lipperweb.com 54 regarding Daxor Corporation 54 Zoraxel 54 immunomodulatory therapy 54 Treatment IND 54 unresectable malignant mesothelioma UMM 54 Epidemiological Studies Unit 54 NCCTG 54 CrossRef Web 54 HDAC Inhibitors 54 Bendamustine 54 http:/tucowsinc.com 54 trastuzumab Herceptin ® 54 Vion Pharmaceuticals 54 www.thelancet.com 54 Xcytrin R 54 www.proiris.com 54 ACCORD Lipid 54 Treatment Reduces 54 relapsed refractory multiple myeloma 54 Premarket Approval Application 54 Pirfenidone 54 ANCHOR trial 54 Chemotherapeutic Agents 54 Patients Receiving 54 PSMA ADC 54 Phase 2a preventative